Milind Javle Selected Research

Milind Javle Research Topics

Disease

92	Neoplasms (Cancer) 05/2024 - 11/2004
36	Cholangiocarcinoma 03/2024 - 07/2007
32	Adenocarcinoma 11/2022 - 05/2004
29	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 02/2009
11	Gallbladder Neoplasms (Gallbladder Cancer) 12/2023 - 01/2013
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023 - 05/2015
8	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2010
7	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 11/2004
6	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2005
6	Carcinoma (Carcinomatosis) 06/2021 - 04/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2009 - 07/2005
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 11/2009
4	Melanoma (Melanoma, Malignant) 02/2024 - 12/2017
4	Disease Progression 10/2021 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 05/2015 - 02/2009
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 03/2010
3	Klatskin Tumor 01/2018 - 05/2011
3	Hemorrhage 10/2013 - 11/2009
2	Microsatellite Instability 03/2024 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 05/2011
2	Residual Neoplasm 02/2023 - 01/2022
2	Nausea 01/2021 - 02/2017
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2018
2	Neutropenia 01/2018 - 11/2010
2	Carcinogenesis 02/2016 - 05/2004
2	Hypertension (High Blood Pressure) 12/2014 - 09/2007
2	Drug-Related Side Effects and Adverse Reactions 11/2010 - 01/2010
2	Rectal Neoplasms (Rectal Cancer) 03/2010 - 12/2005
1	Inflammation (Inflammations) 03/2024

Drug/Important Bio-Agent (IBA)

23	Gemcitabine FDA Link 01/2022 - 08/2005
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2010
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2004
9	Capecitabine (Xeloda)FDA Link 11/2022 - 08/2005
9	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 08/2005
6	Cell-Free Nucleic AcidsIBA 11/2023 - 09/2017
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 08/2007
6	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2004
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2014
4	RNA (Ribonucleic Acid)IBA 05/2024 - 06/2014
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 02/2009
4	Bevacizumab (Avastin)FDA Link 04/2022 - 09/2007
4	infigratinibIBA 10/2021 - 01/2018
4	LigandsIBA 12/2020 - 01/2014
4	AntigensIBA 10/2020 - 11/2017
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2007
3	human ERBB2 proteinIBA 05/2024 - 03/2010
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024 - 12/2016
3	Circulating Tumor DNAIBA 02/2023 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 02/2023 - 11/2004
3	VemurafenibIBA 02/2023 - 01/2019
3	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 02/2009
3	130-nm albumin-bound paclitaxelIBA 11/2022 - 02/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022 - 01/2019
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 08/2007
3	ParaffinIBA 01/2020 - 12/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 10/2013
3	Monoclonal AntibodiesIBA 01/2018 - 12/2014
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 05/2011
2	InterferonsIBA 05/2024 - 12/2011
2	futibatinibIBA 11/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2022
2	Mitogen-Activated Protein KinasesIBA 02/2022 - 01/2020
2	RamucirumabIBA 01/2022 - 12/2014
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 12/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2021 - 04/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2021 - 04/2011
2	PlatinumIBA 05/2021 - 09/2015
2	pertuzumabIBA 01/2021 - 05/2015
2	trametinibIBA 01/2020 - 01/2020
2	folfirinoxIBA 01/2020 - 01/2019
2	Calcitriol (Calcijex)FDA LinkGeneric 10/2018 - 11/2005
2	dalotuzumabIBA 01/2018 - 12/2014
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2016 - 12/2016
2	ChromatinIBA 11/2016 - 01/2014
2	MetalsIBA 12/2011 - 05/2011
2	Docetaxel (Taxotere)FDA Link 01/2010 - 08/2005
2	Trefoil Factor-3IBA 07/2007 - 01/2005
1	GenieIBA 05/2024
1	zanidatamabIBA 02/2024
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 02/2024
1	Interleukin-2 (IL2)IBA 02/2024
1	urelumabIBA 02/2024

Therapy/Procedure

60	Therapeutics 02/2024 - 07/2005
33	Drug Therapy (Chemotherapy) 02/2024 - 12/2005
13	Radiotherapy 09/2023 - 09/2006
6	Immunotherapy 02/2024 - 07/2018
6	Neoadjuvant Therapy 01/2023 - 07/2007
6	Pancreatectomy 01/2022 - 03/2007
5	Liver Transplantation 01/2022 - 01/2018
5	Chemoradiotherapy 08/2015 - 01/2010
4	Contraindications 01/2022 - 01/2018
4	Stents 01/2018 - 09/2006
4	Pancreaticoduodenectomy 01/2017 - 12/2011
2	Aftercare (After-Treatment) 11/2023 - 08/2008
2	Induction Chemotherapy 11/2022 - 12/2016
2	Precision Medicine 01/2021 - 06/2020
2	Palliative Care (Palliative Therapy) 08/2015 - 05/2011